Gender Development Index
Gender Development Index (GDI) is a measure reflecting the inequalities between men and women in a country. It is based on the Human Development Index (HDI) and is calculated for both genders in the same three dimensions as the HDI: health, measured by life expectancy at birth; education, measured by mean years of schooling for adults aged 25 years or more and expected years of schooling for children entering school; and standard of living, measured by gross national income per capita.
The GDI is designed to show the gap in human development achievements between women and men. It is calculated as the ratio of the female to the male HDI values. A GDI value of 1 indicates perfect equality between genders; a value less than 1 indicates that a country is doing better in HDI terms for men than for women.
Calculation[edit | edit source]
The GDI is calculated by taking the average of three gender-specific indices for each of the HDI dimensions. The formula for each gender-specific index is the same as that used for calculating the HDI, but the values used are specific to males or females. The GDI is then the ratio of the female HDI to the male HDI.
Importance[edit | edit source]
The GDI is an important tool for policymakers and researchers as it provides a more nuanced view of inequalities in human development. By focusing on gender disparities, it highlights areas where policies can be targeted to improve equality between men and women. This is crucial for achieving sustainable development goals, as gender equality is not only a fundamental human right but also a necessary foundation for a peaceful, prosperous, and sustainable world.
Criticisms[edit | edit source]
While the GDI is a valuable tool for highlighting gender disparities in human development, it has faced criticism. Some argue that it does not fully capture the complexities of gender inequality, such as differences in power, opportunities, and choices. Others point out that the GDI relies on data that may not be available or reliable in all countries, potentially leading to inaccuracies.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD